Healthcare -
Biotechnology - NASDAQ - US
$ 4.8325
124 %
$ 15 M
Market Cap
-0.15
P/E
BTAI - ACCOUNTS PAYABLE
Accounts Payable BTAI - BioXcel Therapeutics, Inc.
13.7 M
LAST VALUE
70.84%
2 YEAR CAGR
53.47%
5 YEAR CAGR
0.00%
10 YEAR CAGR